{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T14:37:27Z","timestamp":1773412647044,"version":"3.50.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.berh.2004.10.003","type":"journal-article","created":{"date-parts":[[2005,4,27]],"date-time":"2005-04-27T11:41:43Z","timestamp":1114602103000},"page":"263-276","source":"Crossref","is-referenced-by-count":60,"title":["What do antineutrophil cytoplasmic antibodies (ANCA) tell us?"],"prefix":"10.1016","volume":"19","author":[{"given":"Judy","family":"Savige","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Trevisin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2004.10.003_bib1","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/bmj.285.6342.606","article-title":"Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology?","volume":"285","author":"Davies","year":"1982","journal-title":"Br Med J"},{"key":"10.1016\/j.berh.2004.10.003_bib2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(85)91147-X","article-title":"Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis","volume":"1","author":"Van der Woude","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2004.10.003_bib3","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(87)90591-5","article-title":"Prospective study of radioimmunoassay for antibodies against neutrophil cytoplasm in diagnosis of systemic vasculitis","volume":"I","author":"Savage","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2004.10.003_bib4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0025-6196(12)65300-2","article-title":"Anticytoplasmic autoantibodies in the diagnosis and follow up of Wegener's granulomatosis","volume":"64","author":"Specks","year":"1989","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.berh.2004.10.003_bib5","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM198806233182504","article-title":"Antineutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotising and crescentic glomerulonephritis","volume":"318","author":"Falk","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.berh.2004.10.003_bib6","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1046\/j.1523-1755.2000.057003846.x","article-title":"Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features","volume":"57","author":"Savige","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.berh.2004.10.003_bib7","first-page":"176","article-title":"Classical polyarteritis nodosa, and microscopic polyarteritis with medium vessel involvement\u2014a comparison of the clinical and laboratory features","volume":"47","author":"Kirkland","year":"1997","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.berh.2004.10.003_bib8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/thx.46.1.70","article-title":"Antimyeloperoxidase antibodies in the Churg Strauss syndrome","volume":"46","author":"Cohen Tervaert","year":"1991","journal-title":"Thorax"},{"key":"10.1016\/j.berh.2004.10.003_bib9","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/rheumatology\/35.10.958","article-title":"Antineutrophil cytoplasmic antibodies, abnormal angiograms and pathological findings in polyarteritis nodosa and Churg-Strauss syndrome: indications for the classification of vasculitides of the polyarteritis Nodosa group","volume":"35","author":"Guillevin","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.berh.2004.10.003_bib10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/jcp.52.2.124","article-title":"Diagnostic value of classical and atypical antineutrophil cytoplasmic antibody (ANCA) immunofluorescence patterns","volume":"52","author":"Wong","year":"1999","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.berh.2004.10.003_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1568-9972(01)00007-6","article-title":"Neutrophil-specific autoantibodies in chronic inflammatory bowel diseases","volume":"1","author":"Wiik","year":"2002","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.berh.2004.10.003_bib12","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/ajcp\/111.4.507","article-title":"International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA)","volume":"111","author":"Savige","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.berh.2004.10.003_bib13","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1182\/blood.V74.6.1888.1888","article-title":"Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase","volume":"74","author":"Niles","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.berh.2004.10.003_bib14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-2249.1995.tb03471.x","article-title":"Bactericidal\/permeability increasing (BPI) protein is an important antigen for antineutrophil cytoplasmic autoantibodies (ANCA) in vasculitis","volume":"99","author":"Zhao","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.berh.2004.10.003_bib15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1365-2249.1996.d01-738.x","article-title":"Frequency of antibactericidal\/permeability increasing protein (BPI) and antiazurocidin in patients with renal disease","volume":"105","author":"Yang","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.berh.2004.10.003_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-2249.1997.d01-907.x","article-title":"Novel autoantigens of perinuclear antineutrophil cytoplasmic antibodies (P-ANCA) in ulcerative colitis: non-histone chromosomal proteins, HMG1 and HMG2","volume":"107","author":"Sobajima","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.berh.2004.10.003_bib17","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0140-6736(93)91761-A","article-title":"Vasculitis and antineutrophil cytoplasmic antibodies associated with propylthiouracil therapy","volume":"342","author":"Dolman","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2004.10.003_bib18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/07435809809135527","article-title":"Antineutrophil cytoplasmic antibodies in autoimmune thyroid disorders","volume":"24","author":"Afeltra","year":"1998","journal-title":"Endocr Res"},{"key":"10.1016\/j.berh.2004.10.003_bib19","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1530\/eje.0.1420587","article-title":"Prevalence of positive antineutrophil cytoplasmic antibody (ANCA) in patients receiving antithyroid medication","volume":"142","author":"Gunton","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.berh.2004.10.003_bib20","first-page":"775","article-title":"Antigen specificity in hydralazine associated ANCA positive systemic vasculitis","volume":"8","author":"Short","year":"1995","journal-title":"QJM"},{"key":"10.1016\/j.berh.2004.10.003_bib21","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/0006-2952(79)90692-0","article-title":"Accumulation of 2-[14C]propylthiouracil in human polymorphonuclear leucocytes","volume":"28","author":"Lam","year":"1979","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.berh.2004.10.003_bib22","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/0006-2952(88)90574-6","article-title":"Inactivation of peroxidase of rat bone marrow by repeated administration of propylthiouracil is accompanied by a change in heme structure","volume":"37","author":"Lee","year":"1988","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.berh.2004.10.003_bib23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/1529-0131(200002)43:2<405::AID-ANR22>3.0.CO;2-5","article-title":"Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis","volume":"43","author":"Choi","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2004.10.003_bib24","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1002\/1529-0131(200011)43:11<2488::AID-ANR16>3.0.CO;2-X","article-title":"Evaluation of antineutrophil cytoplasmic antibody seroconversion induced by minocycline, sulphasalazine, or penicillamine","volume":"43","author":"Choi","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2004.10.003_bib25","first-page":"701","article-title":"Antineutrophil cytoplasmic antibodies (ANCA)-associated crescentic glomerulonephritis and propylthiouracil therapy","volume":"73","author":"Yuasa","year":"1996","journal-title":"Nephrology"},{"key":"10.1016\/j.berh.2004.10.003_bib26","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0091-6749(05)80067-3","article-title":"A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease","volume":"86","author":"Saxon","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.berh.2004.10.003_bib27","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/gut.33.5.668","article-title":"Antineutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role","volume":"33","author":"Cambridge","year":"1992","journal-title":"Gut"},{"key":"10.1016\/j.berh.2004.10.003_bib28","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1053\/gast.1996.v110.pm8964407","article-title":"Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup","volume":"110","author":"Vasiliauskas","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.berh.2004.10.003_bib29","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1136\/bmj.297.6656.1105","article-title":"Antibody to Saccharomyces cerevisiae in Crohn's disease","volume":"297","author":"Main","year":"1988","journal-title":"Br Med J"},{"key":"10.1016\/j.berh.2004.10.003_bib30","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/gut.42.6.788","article-title":"Antisaccharomyces cerevisiae mannose antibodies combined with antineutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role","volume":"42","author":"Quinton","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.berh.2004.10.003_bib31","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF01541319","article-title":"Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: ulcerative colitis, type I autoimmune hepatitis, and primary sclerosing cholangitis","volume":"15","author":"Vidrich","year":"1995","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.berh.2004.10.003_bib32","first-page":"255","article-title":"Autoantibodies to neutrophil cytoplasmic enzymes in Felty's syndrome","volume":"11","author":"Coremans","year":"1993","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2004.10.003_bib33","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-2249.1991.tb05779.x","article-title":"Antineutrophil cytoplasm antibodies in rheumatoid arthritis","volume":"86","author":"Savige","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.berh.2004.10.003_bib34","first-page":"541","article-title":"Antineutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlations with other autoantibodies","volume":"16","author":"Galeazzi","year":"1998","journal-title":"Clin Exp Rheumat"},{"key":"10.1016\/j.berh.2004.10.003_bib35","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1445-5994.1996.tb02954.x","article-title":"Specificity of cANCA for Wegener's granulomatosis","volume":"26","author":"Nolan","year":"1996","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.berh.2004.10.003_bib36","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/qjmed\/89.4.259","article-title":"Autoantibodies against bactericidal\/permeability-increasing protein in patients with cystic fibrosis","volume":"89","author":"Zhao","year":"1996","journal-title":"QJM"},{"key":"10.1016\/j.berh.2004.10.003_bib37","first-page":"15","article-title":"The presence of cytoplasmic antineutrophil cytoplasmic antibodies (C-ANCA) in the course of subacute bacterial endocarditis with glomerular involvement, coincidence or association?","volume":"49","author":"Subra","year":"1998","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.berh.2004.10.003_bib38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2249.1997.498-ce1395.x","article-title":"Antineutrophil cytoplasmic antibody (ANCA) in malaria is directed against cathepsin G","volume":"110","author":"Yahya","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.berh.2004.10.003_bib39","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1365-2249.1994.tb06578.x","article-title":"Invasive amoebiasis is associated with the development of antineutrophil cytoplasmic antibody","volume":"97","author":"Pudifin","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.berh.2004.10.003_bib40","first-page":"783","article-title":"Antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis after immunisation with bacterial proteins","volume":"20","author":"Savige","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2004.10.003_bib41","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides: proposal of an international consensus conference","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2004.10.003_bib42","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","article-title":"The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis","volume":"33","author":"Leavitt","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2004.10.003_bib43","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0272-6386(12)80877-8","article-title":"Antineutrophil cytoplasmic autoantibody-associated diseases: a pulmonologist's perspective","volume":"18","author":"DeRemee","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.berh.2004.10.003_bib44","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/ki.1998.36","article-title":"Diagnostic predictive value of ANCA serology","volume":"53","author":"Jennette","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.berh.2004.10.003_bib45","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archinte.162.13.1509","article-title":"Using antineutrophil cytoplasmic antibody testing to diagnose vasculitis. Can test ordering guidelines improve diagnostic accuracy?","volume":"162","author":"Mandl","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.berh.2004.10.003_bib46","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1172\/JCI0215918","article-title":"Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice","volume":"110","author":"Xiao","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.berh.2004.10.003_bib47","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1136\/jcp.55.9.680","article-title":"Immunofluorescent patterns produced by antineutrophil cytoplasmic antibodies (ANCA) vary depending on neutrophil substrate and conjugate","volume":"55","author":"Pollock","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.berh.2004.10.003_bib48","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-1759(97)00203-2","article-title":"Capture ELISA based on recombinant PR3 is sensitive for PR3-ANCA testing and allows detection of PR3 and PR3-ANCA\/PR3 immunecomplexes","volume":"211","author":"Sun","year":"1998","journal-title":"J Immunol Meth"},{"key":"10.1016\/j.berh.2004.10.003_bib49","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1046\/j.1523-1755.1998.00873.x","article-title":"Clinical evaluation of a capture ELISA for detection of proteinase 3 antineutrophil cytoplasmic antibody","volume":"53","author":"Westman","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.berh.2004.10.003_bib50","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/ndt\/gfg553","article-title":"The role of flow cytometric ANCA detection in screening for acute pauci-immune crescentic glomerulonephritis","volume":"19","author":"Kitching","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.berh.2004.10.003_bib51","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/jcp.52.6.475","article-title":"Pitfalls of formalin fixation for determination of antineutrophil cytoplasmic antibodies","volume":"52","author":"Chowdhury","year":"1999","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.berh.2004.10.003_bib52","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1046\/j.1523-1755.1998.00807.x","article-title":"Diagnostic value of standardised assays for antineutrophil cytoplasmic antibodies in idiopathic systemic vasculitis: EC\/BCR project for ANCA assay standardisation","volume":"53","author":"Hagen","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.berh.2004.10.003_bib53","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/jcp.52.9.670","article-title":"ELISA is the superior method for detecting antineutrophil cytoplasmic antibodies in the diagnosis of systemic necrotising vasculitis","volume":"52","author":"Harris","year":"1999","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.berh.2004.10.003_bib54","first-page":"629","article-title":"How and why should we detect ANCA?","volume":"18","author":"Segelmark","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2004.10.003_bib55","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1006\/clim.2001.5200","article-title":"Detection of antineutrophil cytoplasmic antibodies under actual clinical testing conditions","volume":"103","author":"Russell","year":"2002","journal-title":"Clin Immunol"},{"key":"10.1016\/j.berh.2004.10.003_bib56","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/rheumatology\/41.11.1313","article-title":"A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis","volume":"41","author":"Csernok","year":"2002","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2004.10.003_bib57","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/1529-0131(200012)13:6<424::AID-ART14>3.0.CO;2-Q","article-title":"Test characteristics of immunofluorescence and ELISA tests in 856 consecutive patients with possible ANCA-associated conditions","volume":"3","author":"Stone","year":"2000","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.berh.2004.10.003_bib58","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/rheumatology\/keh028","article-title":"Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study","volume":"43","author":"Csernok","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2004.10.003_bib59","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0140-6736(90)92205-V","article-title":"Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titer","volume":"336","author":"Cohen Tervaert","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2004.10.003_bib60","first-page":"127","article-title":"ANCA and predicting relapse in systemic vasculitis","volume":"88","author":"Jayne","year":"1995","journal-title":"QJM"},{"key":"10.1016\/j.berh.2004.10.003_bib61","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1097\/01.ASN.0000093256.18266.22","article-title":"High proteinase 3-antineutrophil cytoplasmic antibody (ANCA) level measured by the capture enzyme-linked immunosorbent assay method is associated with decreased patient survival in ANCA-associated vasculitis with renal involvement","volume":"14","author":"Westman","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.berh.2004.10.003_bib62","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1681\/ASN.V9101915","article-title":"Determination of renal outcome in antimyeloperoxidase associated glomerulonephritis","volume":"9","author":"Franssen","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.berh.2004.10.003_bib63","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1046\/j.1523-1755.2003.00821.x","article-title":"Serial ANCA titers: useful tool for prevention of relapses in ANCA-associated vasculitis","volume":"63","author":"Han","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.berh.2004.10.003_bib64","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O","article-title":"Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels","volume":"43","author":"Boomsa","year":"2000","journal-title":"Arthritis Rheum"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694204001603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694204001603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T21:58:20Z","timestamp":1625867900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694204001603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S1521694204001603"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2004.10.003","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}